Home Overview Press Room Blog Publications For Students about us
Search

About Biopolitics, Parties, Pundits & Human Biotechnology


Policy decisions about human biotechnologies have typically been debated among elite commissions and experts. But controversy is increasingly spilling over into mainstream news media and political debates.

This trend has been most notable in the United States, with the emergence of human embryonic stem cell research as a political issue. Stem cell debates at the policy level have made this discussion far more visible to the public.

The Bush Administration's restrictions on federal funding for human embryonic stem cell research elevated the issue to the front pages of newspapers. Shortly after its announcement in 2001, partisan battle lines were drawn in ways that mirror the abortion rights divide.

Republicans hoped that opposition to research that destroys embryos would increase support among their party's religious conservative base. Democrats countered by assembling a coalition of patient advocates, biomedical researchers, and biotechnology entrepreneurs and appealed to moderate swing voters and Republicans who they believed would be swayed by promises of cures.

There were some notable exceptions to this partisan line-up. Some conservatives support embryonic stem cell research; some liberals and progressives who support the research in principle criticize aspects of its conduct and regulation. Unfortunately, the polarized debate has frequently distorted facts while obscuring a range of important social issues unrelated to the moral status of embryos.



Human Stem Cell Cloning: 'Holy Grail' or Techno-Fantasy?by David KingCNNMay 17th, 2013There is definitely something special about this idea of "therapeutic cloning," something that has a religious feel to it. We are told that there will be great medical benefits and that the risks that there will be cloned babies are small, but in truth it's the other way round.
Cloning-Derived Stem Cells Raise Policy Questionsby Jessica CussinsBiopolitical TimesMay 16th, 2013Yesterday’s announcement that stem cells have been derived from cloned human embryos set off a media flurry, but important questions about reproductive cloning and women’s health were not widely addressed.
Branstad Signs Bill Widening DNA Sampling to Misdemeanor CasesAssociated PressMay 16th, 2013People convicted of certain aggravated misdemeanors in Iowa now will be required to submit DNA samples to the federal DNA database.
Cloning, Stem Cells Long Mired In Legislative Gridlock[Quotes CGS's Marcy Darnovsky]by Julie RovnerNPRMay 16th, 2013The news that U.S. scientists have successfully cloned a human embryo seems almost certain to rekindle a political fight that has raged, on and off, since the announcement of the creation of Dolly the sheep in 1997.
US Scientists With Cloning Techniques Created Human Embryonic Stem Cells[Quotes CGS's Marcy Darnovsky]MercoPressMay 16th, 2013Stem cells have been a research focus for more than a decade because they can morph into any type of cell, potentially leading to treatments to replace damaged cells and organs. But along with the promise of the technology has come ethical questions and worry over human clones.
What We Mean When We Say 'Race Is a Social Construct'by Ta-Nehisi CoatesThe AtlanticMay 15th, 2013If you tell me that you plan to study "race and intelligence" then it is only fair that I ask you, "What do you mean by race?"
Research cloning development underscores the need for US to prohibit reproductive cloning[Press statement]May 15th, 2013Legislation should be put in place immediately, says public interest group
EEOC Files and Settles Its First GINA-based Employment Discrimination Lawsuitby Jennifer K. WagnerGenomics Law ReportMay 13th, 2013Although individuals have brought complaints against employers alleging violations, this is the first lawsuit initiated by the EEOC to enforce the Genetic Information Nondiscrimination Act.
Modesto Woman Gets 5 Years in Prison for Surrogacy Scamby Carlos SaucedoABC LocalMay 13th, 2013The owner of a Modesto surrogate agency accused of a $2 million fraud scheme has been sentenced in federal court.
Talking Biopolitics is Back!by Jessica CussinsBiopolitical TimesMay 13th, 2013A series of live web-based conversations with cutting-edge thinkers on the social meaning of human biotechnologies will be kicking off next week. RSVP now to join the conversations!
Conservative Immigration Scholar: Black and Hispanic Immigrants Are Dumber Than European Immigrantsby Adam SerwerMother JonesMay 8th, 2013Jason Richwine, who coauthored a Heritage Foundation study on immigration, didn't just argue that certain minorities are dumber in his scholarship—he also said it at a public panel.
A Petition for Change in Memory of Dan Markingsonby Emily Smith BeitiksBiopolitical TimesMay 8th, 2013The story of a young man’s premature death illustrates the medical-industrial complex at its worst.
ACMG Issues Clarification Over Incidental Findings Guidanceby Dr Philippa Brice and Dr Ron ZimmernPHG FoundationMay 7th, 2013The American College of Medical Genetics has released a clarification of recent guidance issued on the subject of incidental findings in clinical genomics.
The Real Problems With Psychiatryby Hope ReeseThe AtlanticMay 2nd, 2013A psychotherapist contends that the DSM, psychiatry's "bible" that defines all mental illness, is not scientific but a product of unscrupulous politics and bureaucracy.
California Lawmakers Consider Paying Women to Provide Eggs for Researchby Diane ToberBiopolitical TimesMay 2nd, 2013A new bill claims to be motivated by concerns for women’s equity and for advancing responsible medical research, but in fact undermines both.
DNA at 60: Still Much to Learn by Philip BallScientific AmericanApril 28th, 2013On the diamond jubilee of the double helix, we should admit that we don't fully understand how evolution works at the molecular level.
“World's First GM Babies Born”: 12-Year-Old Article Continues to Cause Confusionby Jessica CussinsBiopolitical TimesApril 25th, 2013An undated Daily Mail article that is actually over a decade old continues to spread misinformation about human genetic modification.
Earth Day in Biopoliticsby Jessica CussinsBiopolitical TimesApril 22nd, 2013In honor of Earth Day, let’s hope for a move away from “greenwashed” PR stunts and techno-fixes toward conservation, sustainability, and social responsibility.
In Australia, Gene Patents Also Subject of High Court Struggleby Leigh DaytonScienceApril 19th, 2013Australia's Full Federal Court has begun proceedings in an appeal of an earlier decision that upheld the validity of breast cancer diagnostic tests developed by Myriad Genetics.
Can Human Genes Be Patented?by Eliot MarshallScienceApril 17th, 2013The question has been debated for years but not addressed directly by the U.S. Supreme Court—until this week. The decision, expected later this year and from which there is no appeal, could have an impact on hundreds of companies and thousands of researchers.
Which Comes First: The Woman or Her Eggs? [Quotes CGS's Marcy Darnovsky]by Ruha BenjaminHuffington PostApril 17th, 2013If we're going to support a "right to stem cell research," then we need to guarantee a right to health in the form of serious investment in egg donor safety.
Panel Discusses the Legality of Patenting Human Genes [VIDEO][With CGS's Marcy Darnovsky] China Central TelevisionApril 16th, 2013Discussion of the Supreme Court hearing on human gene patents with intellectual property attorney Geoffrey Karny and CGS's Marcy Darnovsky, hosted by Mike Walter.
Watching the Watchers: Lessons From the Science of Science Adviceby Sheila JasanoffThe Guardian April 15th, 2013Who ensures the rationality of science advisers, making sure that they will be held accountable for the integrity of their advice?
Supreme Court Critical of Patents on Human Genesby David G. SavageLos Angeles TimesApril 15th, 2013The justices were highly skeptical of the idea that a company or a scientist can hold a patent on human genes and prevent others from testing or using them.
New “Semisynthetic” Anti-Malarial Drug is Unneeded and Sets Dangerous Precedent While Threatening Farmer Livelihoods[Press Release]SynBioWatchApril 15th, 2013A pharmaceutical giant announced that it will replace the entire world supply of the preferred anti-malarial treatment with a semi-synthetic product produced using synthetic biology - a controversial, unregulated biotechnology.
The Right to Speak Out[Editorial]NatureApril 9th, 2013Controversy over the results touted by a genetic-ancestry firm has highlighted the need for reform of the United Kingdom’s restrictive libel law.
Three-Parent Children in UK Possible After HFEA Report[Quotes the Center for Genetics and Society]by Michael CookBioEdgeApril 6th, 2013The UK fertility regulator's report to the government misrepresented its own findings about public opinion.
Shifts in the Global Body Market: Access or Exploitation?by Jessica CussinsBiopolitical TimesApril 1st, 2013PlanetHospital claims that new surrogacy regulations in India have ruined a “golden opportunity” and paints Mexico and Thailand as the surrogacy frontiers – where it happens to have business arrangements.
GM Crops Evil, GM Children OK?by Chris BennettWestern Farm PressMarch 27th, 2013China is surging ahead with a research project aimed at identifying millions of genetic variations in order to boost intelligence.
Stem-Cell Ruling Riles Researchersby Alison AbbottNatureMarch 26th, 2013The Italian health minister’s support for an unproven stem cell treatment appalls the country’s scientists.
You Don't "Own" Your Own Genes[Press release]Weill Cornell Medical CollegeMarch 25th, 2013Through more than 40,000 patents on DNA molecules, companies have essentially claimed the entire human genome for profit.
Sperm Donor with Genetic Illness Speaks Outby PSThe Copenhagen PostMarch 25th, 2013A former sperm donor may have passed on a heritable and treatable cancer-causing illness, but health authorities have decided not to search for the five to ten children who may be affected.
Beyond Tokenistic Inclusion: Science, Citizenship, and Changing the Questions by Ruha BenjaminHuffington PostMarch 25th, 2013The scientific community prides itself on free and open inquiry, and yet when it comes to raising questions about the social and political implications of our work, a peculiar form of self-censorship seems to be at work.
Privacy and Progress Inspires California Genetic Information Privacy Billby Nicolle StrandPresidential Commission for the Study of Bioethical IssuesMarch 12th, 2013A California State Senator introduced a bill declaring the intent of the legislature to enact new, comprehensive genetic privacy protections in the state.
California Bill Seeks Pay for Women Who Donate Eggs for Researchby Melody GutierrezThe Sacramento BeeMarch 10th, 2013A recently introduced bill in California seeks to overturn existing policies that limit payments to women who provide eggs for research to reimbursement for their expenses.
GM Babies?by Jessica CussinsBiopolitical TimesMarch 5th, 2013A debate about genetically engineered babies is hijacked by slick rhetoric.
UCSF Discovery a Potential "Earthquake" for Stem Cell Therapiesby Ron LeutySan Francisco Business TimesMarch 4th, 2013A new type of stem cell may open new possibilities for fixing damaged parts of the body.
Surrogacy Laws May Leave Australian Babies Statelessby Kerry BrewsterABC News [Australia]March 4th, 2013Australian babies may be left stateless and unable to leave India as a result of changes to the country's commercial surrogacy laws.
BRCA1 gene patent ruling to be appealedby Amy CorderoyThe Age [Australia]March 4th, 2013The decision in Australia that private companies can control human genes will be appealed in the Federal Court.
Meet the New Eugenics, Same as the Old Eugenicsby Gina Maranto, Biopolitical Times guest contributorBiopolitical TimesMarch 4th, 2013According to a new wave of eugenic advocacy, “we” have a “moral obligation” to enhance future generations.
What Is a Gene And How Does it Apply to the Law? The Supreme Court Still Doesn't Know.by Brian ResnickNational JournalMarch 2nd, 2013DNA was discovered 60 years ago this week, and since then it's been muddling up the legal system.
Guidelines for Genetic Testing of Childrenby Pete ShanksBiopolitical TimesFebruary 28th, 2013A new policy statement from the American Academy of Pediatrics and the American College of Medical Genetics discusses when doctors should suggest a genetic test for a child.
Eric Lander Weighs in on Gene Patenting Caseby Carolyn Y. JohnsonThe Boston GlobeFebruary 26th, 2013A leading geneticist has filed an amicus brief arguing that Myriad has patented products of nature, which are ineligible for such protection.
Justices Wrestle Over Allowing DNA Sampling at Time of Arrestby Adam LiptakThe New York TimesFebruary 26th, 2013The Supreme Court heard arguments in a case that one justice said is "perhaps the most important criminal procedure case that this court has heard in decades.”
Can They Patent Your Genes?by Daniel J. KevlesThe New York Review of BooksFebruary 25th, 2013This spring, the Supreme Court will hear a case that may well decide whether genes can be patented, and the consequences for American biomedicine could be huge.
DNA and the Constitution[Editorial]The New York TimesFebruary 24th, 2013The substantial harm to innocent people that could result from the misuse of DNA greatly outweighs the benefits. And the safeguard against such harm is the Fourth Amendment, whose fundamental protections the Maryland court upheld. The Supreme Court should do likewise.
Al Gore: Human Biotech is a “Driver of Global Change”by Marcy DarnovskyBiopolitical TimesFebruary 21st, 2013In his recently released best-seller The Future: Six Drivers of Global Change, Al Gore calls for protocols to guide decisions about human genetic modification.
A Call for International Prohibition of Forced Genital-Normalizing Surgery and Sterilizationby Jessica CussinsBiopolitical TimesFebruary 21st, 2013A new report from the United Nations Special Rapporteur on Torture focuses on human rights abuses in health-care settings, and bolsters LGBTQI activists in their fight against involuntary sterilizations and genital-normalizing surgeries.
Billionaires Anoint Biogeeksby Matthew HerperForbesFebruary 20th, 2013A group of Silicon Valley billionaires announced awards of $3 million to each of eleven recipients, in the first round of their "Breakthrough Prize in Life Sciences."
Sale of Personal Gene Data Condemned as 'Unethical and Dangerous'by Jamie DowardThe Guardian February 16th, 2013Critics say companies could acquire personal information that would identify National Health Service patients without their consent.
Exaggerations and Misrepresentations Have No Place in Science Policy Debatesby Jeremy GruberCouncil for Responsible GeneticsFebruary 15th, 2013A recent debate on whether we should prohibit genetically engineered babies wound up focusing on mitochondrial replacement techniques.
Synthetic Biology and the “Bioeconomy”: Feeding Fuel to the Fire of Landgrabs and Biodiversity Lossby Eric Hoffman and Jeff ConantGlobal Forest CoalitionFebruary 14th, 2013The new industrialists want to use synthetic biology techniques to turn microbes into “living chemical factories” engineered to produce biofuels, bio-plastics, industrial chemicals and oils, and even medicines.
Stem Cells in Texas: Cowboy Cultureby David CyranoskiNatureFebruary 13th, 2013By offering unproven therapies, a Texas biotechnology firm has sparked a bitter debate about how stem cells should be regulated.
Yes, Virginia, Your Reproductive Rights Are Compromised by Alex SternHuffington PostFebruary 12th, 2013In Virginia as in many other states, legislative battles about reproductive rights are front and center. One pending bill proposes reparations for victims of the state's eugenic sterilization policy; the other seeks to end the 30-day waiting period for sterilization.
Too Much InformationSupreme Court 2013: Why collecting DNA from people who are arrested won’t help solve more crimes.by Brandon L. Garrett and Erin MurphySlateFebruary 12th, 2013Research shows that police solve more crimes not by taking DNA from suspects who have never been convicted, but by collecting more evidence at crime scenes.
Inside China’s Genome FactorySequencing a complete human genome may soon cost less than an iPhone. Will BGI-Shenzhen decode yours? by Christina LarsonTechnology ReviewFebruary 11th, 2013BGI-Shenzhen has become the world’s most prolific sequencer of human, plant, and animal DNA. So far, it claims to have completely sequenced some 50,000 human genomes — far more than any other group.
Will Pre-Conviction DNA Collection Become the National Norm?by Jessica CussinsBiopolitical TimesFebruary 7th, 2013The United States Supreme Court will hear a case later this month that will determine the legality of collecting DNA from people who are arrested for but not convicted of any crime.
Promoting the Civil Rights of Children Born With Variations of Sex AnatomyAdvocates for Informed ChoiceFebruary 6th, 2013The UN Special Rapporteur on Torture calls upon all States to repeal any law allowing intrusive and irreversible treatments, including forced genital-normalizing surgery, involuntary sterilization, and unethical experimentation.
Eugenics Compensation Bill Sidelined in Va. Houseby Bill SizemoreThe Virginian-PilotFebruary 5th, 2013A bipartisan proposal to compensate Virginians who were involuntarily sterilized during the eugenics era is going nowhere, sidelined by its potential price tag.
Arrivederci, GINAby Alex PhilippidisGenetic Engineering & Biotechnology NewsFebruary 4th, 2013A new study demonstrates that individuals can be identified based on personal genetic material they submitted for research.
Supreme Court to Hear Fight Over Taking DNA From Arrested Peopleby David SavageLos Angeles TimesFebruary 2nd, 2013The Supreme Court will hear a privacy rights challenge to the police practice of taking DNA from people arrested but not convicted.
Proposal to Collect DNA From Immigrants Too Orwellian: Opinion by Opinion staffDaily NewsJanuary 31st, 2013Undocumented immigrants should not be required to submit DNA samples as a condition of staying in the United States.
State Lawmaker Wants To Take All Misdemeanor Offenders’ DNACBS DenverJanuary 30th, 2013Colorado already collects DNA from the worst felons. Now there’s a proposal to follow in New York's footsteps and add the DNA of people convicted of misdemeanors.
Hilary Rose: The Problem with the Bioscience Industry – Videoby Hilary RoseThe GuardianJanuary 30th, 2013Hilary Rose, co-author of Genes, Cells and Brains, argues that we should treat the medical claims made for genetic research with suspicion.
Biotech Firms, Billions at Risk, Lobby States to Limit Genericsby Andrew PollackThe New York TimesJanuary 28th, 2013Some of the nation’s biggest biotechnology companies are lobbying intensively to limit generic competition to their blockbuster drugs, potentially cutting into the billions of dollars in savings on drug costs contemplated in the federal health care overhaul law.
Israel Admits Ethiopian Women Were Given Birth Control Shots by Talila NesherHaaretzJanuary 27th, 2013The Health Ministry director general has instructed gynecologists not to inject women with the long-acting contraceptive Depo-Provera if they do not understand the ramifications of treatment.
State Stem Cell Agency Endorses Conflict Guidelinesby Bradley FikesUT San DiegoJanuary 23rd, 2013California’s $3 billion state stem agency voted Wednesday to accept in concept proposed changes to reduce conflicts of interest on the agency's governing committee.
It's Legal For Some Insurers To Discriminate Based On Genesby David SchultzNPRJanuary 17th, 2013The Genetic Information Nondiscrimination Act has a loophole: It only applies to health insurance. It says nothing about life insurance, disability insurance or long-term-care insurance.
Born to Run the World?by Abby Lippman, Biopolitical Times guest contributorBiopolitical TimesJanuary 17th, 2013Forget about glass ceilings, sexism in employment, gender inequities, and all those other structural and societal policies and practices that put obstacles in the way of women (and racialized groups) getting ahead. Maybe they just lack the "leadership gene."
No Easy Answer[Editorial]NatureJanuary 9th, 2013Demands to analyse the DNA of the Connecticut school shooter are misguided and could lead to dangerous stigmatization, or worse.
Book Review: Anne Pollock’s Medicating Race[Quotes CGS's Osagie Obasogie]by Colin HalversonSomatosphereJanuary 7th, 2013Medicating Race is a meditation on the history and present state of racialized (specifically African American) forms of heart disease.
Stem Cell Lawsuit Finally Overby Jocelyn KaiserScience InsiderJanuary 7th, 2013The Supreme Court has rejected a request to ban federally funded research on human embryonic stem cells, bringing an end to a long legal battle.
Could Human Enhancement Turn Soldiers Into Weapons That Violate International Law? Yesby Patrick LinThe AtlanticJanuary 4th, 2013New technologies reveal ambiguities and hidden assumptions in international humanitarian law.
New Guidelines: India Not A Viable Option For Gay Couples, Unmarried Couples Or Single Individualsby Andrew VorzimerThe Spin DoctorJanuary 4th, 2013India’s Ministry of Home Affairs has released guidelines that apply to foreign nationals seeking an Indian surrogate.
As a Girl in India, I Learned to Be Afraid of Menby Mira KamdarThe AtlanticJanuary 4th, 2013Sex-selective abortion, female infanticide and the sheer neglect of girls have made for a growing gender gap in India. In the wake of the brutal gang rape of a young paramedical student in Delhi, Indian citizens have taken to the streets to show their outrage.
Are We Entering the Age of the $1 Million Medicine? by Ben HirschlerReutersJanuary 3rd, 2013The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the price.
DNA Ancestry Testing: What Can it Say about Native American Identity?by Jessica CussinsBiopolitical TimesDecember 20th, 2012The question of who belongs to what Native American tribe is rife with political, social, and legal implications. Do DNA ancestry tests provide answers or add another layer of misunderstanding?
By Hiring Kurzweil, Google Just Killed the SingularityThank God. by John PavlusMIT Technology ReviewDecember 17th, 2012Google announced a jaw-dropping hire: Ray Kurzweil as a Director of Engineering. If he wants to put his ideas into action there, he’ll have no choice but to get real about them.
Genome Challenge Emerges in Society Sharing DNA Benefitsby John LauermanBloomberg BusinessweekDecember 9th, 2012Scientists at a Nobel conference in Stockholm voiced worry that we will end up with a genetic divide, increasing already problematic social inequalities.
U.S. Supreme Court to Decide if Human Genes Patentableby Jonathan StempelReutersNovember 30th, 2012The U.S. Supreme Court has agreed to decide whether human genes can be patented.
After Loss, the Fight to Label Modified Food Continuesby Andrew PollackThe New York TimesNovember 7th, 2012Advocates for the labeling of genetically modified food vowed to carry their fight to other states and to the federal government after a defeat in California.
Leaning Left or Right, Red or Blue? Answer May be in Your Genes[Quotes CGS' Marcy Darnovsky]by Stephen DinanThe Washington TimesNovember 5th, 2012A look at the debate on the role of genetics in determining political preferences. One thing is clear: this is a story of correlation, not causation.
Why Genes Don’t Predict Voting Behaviorby Evan Charney and William EnglishScientific AmericanNovember 5th, 2012Is the claim that a few genes influence political views and actions legitimate? We don't think so.
Personalised Medicine: A Reality Checkby Donna DickensonBioNewsNovember 5th, 2012A look at the economic and political realities that lurk behind the lofty promises made by the advocates of personalised medicine.
The HealerHow Shinya Yamanaka Transformed the Stem-Cell War and Made Everyone a Winnerby William SaletanSlateOctober 9th, 2012Shinya Yamanaka's research on "induced pluripotent stem cells" earned him a Nobel Prize. But much of the media coverage missed half the story. Yamanaka’s venture wasn’t just an experiment. It was a moral project.
Leading Race “Scientist” Dies in Canadaby Don TerrySouthern Poverty Law CenterOctober 6th, 2012Jean Philippe Rushton's death marks the end of an era of academic racism.
Yet Another Study Claims to Find Politics in Our Genes by Jessica CussinsBiopolitical TimesSeptember 6th, 2012A study on genes and political identity comes out just in time for the presidential election, but says little that’s new.
Stem Cells: A Culture War Gone Quiet by Alex Seitz-WaldSalonAugust 23rd, 2012The GOP is so against stem-cell research that it's in the party platform. So why won't Republicans talk about it?
Synthetic Collaborations and Experimental Human Scienceby Daniel SharpBiopolitical TimesJuly 13th, 2012A new book explores how human scientists and natural scientists might interact differently, and raises concerns about synthetic biology.
Genome Test Slammed for Assessing ‘Racial Purity’by Alison AbbottNatureJune 12th, 2012Hungary’s Medical Research Council has asked public prosecutors to investigate a genetic-diagnostic company that certified that a member of parliament did not have Roma or Jewish heritage.
Learning the Right Lessons from Eugenicsby Pete ShanksBiopolitical TimesJune 12th, 2012Ross Douthat's column in The New York Times makes some valid points and some spectacularly ill-judged ones.
N.C. House Approves Measure Compensating Victims of Eugenics Programsby Lynn BonnerNews ObserverJune 5th, 2012In a 86-31 vote, the state House approved a measure that will compensate people sterilized by a state authority over four decades ago.
Bill Banning ‘Sex-Selective Abortions’ Fails in the Houseby Ed O'KeefeWashington PostMay 31st, 2012A measure to ban abortions based on the sex of a fetus failed to pass in a House vote. Opponents of reproductive rights will try to use the vote against Democrats.
Another Anti-Abortion Sting – This Time, Trying to Blame Planned Parenthood for Sex Selection by Marcy DarnovskyBiopolitical TimesMay 15th, 2012An anti-choice sting operation aims to convince Americans that confronting sex selection is best done by restricting reproductive rights.
Should Addicts be Sterilized?by Jed BickmanSalonMay 2nd, 2012Project Prevention has long paid poor, addicted women not to procreate. Now the far right is helping it go global.
White House Plan for New “Bioeconomy” — A Step in the Wrong Direction by Daniel SharpBiopolitical TimesMay 2nd, 2012Unveiling a new “National Bioeconomy Blueprint,” the Obama Administration appeases the biotech industry while taking a step in the wrong direction.
Appeals Court to Hear Gene-Patenting Case in Julyby Maggie FoxNational JournalApril 30th, 2012The next round of hearings for the Myriad gene patents case has been set for July 20th.
Will Gattaca Come True?[Quotes CGS's Marcy Darnovsky]by Mara HvistendahlSlateApril 27th, 2012Noninvasive, early fetal tests for sex, paternity, and chromosomal conditions will change pregnancy dramatically — and raise tricky ethical questions.
White House Promotes a Bioeconomyby Andrew PollackNew York TimesApril 26th, 2012The White House unveils its "National Bioeconomy Blueprint" amidst praise from the biotech industry and dissent from consumer advocates and environmentalists.
The Texas Two-Step: New State Regs Allow Stem Cell Companies to Circumvent FDA Evaluations by Daniel SharpBiopolical TimesApril 19th, 2012New regulations in Texas allow stem cell corporations to circumvent FDA review, raising concerns for health and safety.
Texas Accused of Ignoring FDA on Stem Cell Rulesby Todd AckermanHouston ChronicleApril 10th, 2012Texas' new adult stem cell regulations have drawn criticism for circumventing FDA standards and making questionable practices commercially available.
Playing God?by Steven T. JonesSan Francisco Bay GuardianApril 3rd, 2012SynBioWatch raises concerns about the risks posed by a planned new synthetic biology lab in Richmond.
Union of Concerned Scientists Exposes “Corporatization” of Scienceby Daniel SharpBiopolical TimesMarch 15th, 2012A new Union of Concerned Scientists report addresses the dangers of corporate influence in science, and provides recommendations for governance.
President’s Commission Addresses Informed Consent and Genomics, but Remains Silent on Core Concernsby Daniel SharpBiopolitical TimesFebruary 7th, 2012The President's Commission on Bioethics took up important topics at last week's meeting, but also overlooked some key concerns.
Gingrich Vows to Ban Embryonic Stem-Cell Research, Questions In Vitro Practicesby Karen TumultyWashington PostJanuary 29th, 2012Gingrich makes clear that, if elected, he would ban embryonic stem-cell research.
Genetic Discrimination and Ron Paulby Emily BeitiksBiopolitical TimesJanuary 9th, 2012Genetic discrimination in Canada today is similar to what the US faced prior to the Genetic Information Nondiscrimination Act of 2008, opposed by presidential candidate Ron Paul.
Hoping for Cures, Supporters May Back Another Ballot Measure for Stem Cell Agencyby Steve JohnsonSan Jose Mercury NewsDecember 8th, 2011California's $3 billion taxpayer-financed stem cell agency still has no treatments on the market and is now at a critical juncture that could determine how much longer it stays in operation.
Bill Would Ban Abortions Based on Sex or Raceby David Crary, Associated Press National WriterABC NewsDecember 6th, 2011House Republicans sponsor a bill to ban abortions based on sex, race; critics call it ploy to undermine broader rights.
Celebrating Dorothy Roberts and Fatal Inventionby Doug PetBiopolitical TimesOctober 6th, 2011The Center for Genetics and Society co-sponsored two events celebrating Dorothy Roberts' new book, Fatal Invention: How Science, Politics, and Big Business Re-Create Race in the Twenty-First Century.
Of Dogs, Clones and Rick Perry[Quotes Biopolitical Times' Pete Shanks]by John FarrellForbesSeptember 30th, 2011There's one dog cloning company in the world - and it's the same company that was involved in generating the stem cells Texas Governor Rick Perry had injected into his spine this past July.
Racial Disparities in Funding At NIHby Osagie K. ObasogieBiopolitical TimesSeptember 22nd, 2011Mountains of evidence have shown that racial disparities are prevalent across the health sciences landscape. But new research shows that these disparities do not simply concern traditional issues such as relative rates of asthma or diabetes in certain populations, but also the funding mechanisms used to support scientific research.
NIH Uncovers Racial Disparity in Grant Awardsby Jocelyn KaiserScienceAugust 19th, 2011An analysis of grant data from the National Institutes of Health found significant disparities in funding granted to black Ph.D. scientists and their white counterparts.
New Book on the Biopolitics of Raceby Osagie ObasogieBiopolitical TimesAugust 18th, 2011Dorothy Roberts' new book meets an urgent need: encouraging greater thought and public discussion on what new genetic technologies mean for society’s understanding of racial difference and its commitment to racial justice.
Betting That Biotech Will Bring the FDA to Heel? Don’t Count On Itby Luke TimmermanXconomyJune 30th, 2011Word is that BIO has been working behind the scenes on a series of pro-industry legislative proposals that take aim at the Food and Drug Administration, the agency with the power to make or break companies developing innovative new medical products.
The Serious Intent Behind a Ridiculous Ideaby Pete ShanksBiopolitical TimesJune 7th, 2011More publicity for the Seasteading Institute elicits laughs, but functions as propaganda to normalize extreme ideas.
More Arguing About Human Gene Patents in Courtby Doug PetBiopolitical TimesApril 7th, 2011A Federal Court of Appeals panel heard oral arguments in the Myriad case, but gave no hint of its decision; either way, many expect it to go to the Supreme Court.
Genetic Bill of Rights: Teetering on the brink of Massachusetts law? by Doug PetBiopolitical TimesMarch 31st, 2011The Massachusetts legislature will deliberate on the introduction of a Genetic Bill of Rights next week. Public interest advocates are signing on in support while others oppose.
Feds to Pay States to Expand Forensic DNA Databases?by Pete ShanksBiopolitical TimesJanuary 26th, 2011A newly introduced bill would incentivize states to expand the collection of DNA from people arrested for certain crimes, before trial let alone conviction.
Is Klein a Shoo-In for Chair of California Stem Cell? Maybe, Maybe Not[Commentary]by David JensenCalifornia Stem Cell ReportDecember 5th, 2010If the CIRM board re-elects Klein, it will be indicating to the stem cell community that it tolerates, if not approves of Klein's maladroit attempts to engineer the selection of his successor.
The Corrupting Influence of the Business of Biotechby Pete ShanksBiopolitical TimesNovember 23rd, 2010Many scientists seem oblivious of the potential that industry funding offers for conflicts of interest.
Habermas Warns of Genetic Claims that Bolster Xenophobia by Marcy DarnovskyBiopolitical TimesNovember 4th, 2010One of the most influential living philosophers uses a New York Times op-ed to caution that "false biological conclusions" are fueling discrimination against Muslim immigrants in Germany.
Abolition of HFEA 'won't save anything'BBC NewsSeptember 24th, 2010The former chair of the Human Fertilisation and Embryology Authority, one of many publicly funded non-governmental advisory bodies in the UK that may be scrapped, analyses the gap the abolition of the body will leave.
UK embryo agency faces the axeby Daniel CresseyNatureAugust 3rd, 2010Coalition government promises to abolish respected regulator in effort to cut back on quangos.
Politics Belong in Scienceby Brendan ParentBiopolitical TimesJune 30th, 2010Reflecting on Venter's recent announcement and Obama's call to study Synthetic Biology, Time's Nancy Gibbs clarifies that political engagement with science is essential.
Against the Grain: Progressive Bioethics[Interview with CGS's Marcy Darnovsky]by C.S. SoongAgainst the Grain, KPFA RadioApril 19th, 2010The emergence or specter of biotechnologies like assisted reproduction and human cloning has raised thorny ethical issues. According to Marcy Darnovsky, progressives and radicals have not always approached these issues carefully and thoughtfully. Darnovsky talks about designer babies, surrogacy, stem cell research, and much more.
Tories give up plan to block police retention of DNA samples - for now[United Kingdom]by Francis Elliott and Richard Ford The TimesApril 8th, 2010The Conservative Party has abandoned attempts to block the retention of DNA samples, to pre-empt a Labour campaign leading up to elections.
A Strange Provision in Federal Stem Cell Billby Jesse ReynoldsBiopolitical TimesMarch 22nd, 2010A bill to codify federal embryonic stem cell research policy contains an odd section regarding reproductive cloning.
"Moral Questions of an Altogether Different Kind" [PDF]Progressive Politics in the Biotech Ageby Marcy DarnovskyHarvard Law and Policy ReviewFebruary 23rd, 2010Human genetic, reproductive and biomedical technologies are taking us into uncharted moral and political waters.
Progress in Bioethics: Science, Policy, and Politics[Video featuring CGS's Marcy Darnovsky]Center for American ProgressJanuary 7th, 2010A special presentation at the Center for American Progress in Washington, DC to mark the publication of the anthology "Progress in Bioethics: Science, Policy, and Politics."
Biopolitics for the 21st Centuryby Marcy Darnovsky2020 ScienceDecember 14th, 2009Something is amiss in the interface between emerging technologies and society. Are we less giddy about the techno-future now than we were back in the 20th century? Does technology innovation now serve human needs rather than the imperatives of commerce?
US bioethics commission promises policy actionby Vivki BrowerNatureNovember 30th, 2009President Obama created a new Presidential Commission for the Study of Bioethical Issues, and announced its Chair and Vice Chair.
Promises, Promisesby Stuart BlackmanThe ScientistNovember 1st, 2009Ill-judged predictions and projections can be embarrassing at best and, at worst, damaging to the authority of science and science policy.
Biopolitics, Mythic Science, and Progressive Valuesby Marcy DarnovskyProgress in Bioethics: Science, Policy and Politics; edited by Jonathan D. Moreno and Sam Berger (The MIT Press, 2010)October 16th, 2009Progressive biopolitics can and should draw deeply on our commitments to social justice and the common good, to public-sector oversight, to a precautionary sensibility in the face of powerful technologies, and to the broad inclusion of civil society in democratizing science and science policy.
ACLU Challenges California Prop. 69 by Osagie K. ObasogieBiopolitical TimesOctober 16th, 2009Prop. 69’s arrestee provision marks a radical expansion of the government’s power to indefinitely retain intimate information about citizens – many of whom may have done nothing more than be accused of committing a crime.
Michael Sandel on genetics, morality, and a new politics of the common goodby Marcy DarnovskyBiopolitical TimesSeptember 11th, 2009"It is tempting to think that bioengineering our children and ourselves for success in a competitive society is an exercise of freedom. But changing our nature to fit the world, rather than the other way around, is actually the deepest form of disempowerment."
Political Science [PDF]by Marcy DarnovskyDemocracy (Summer 2009)Some progressives came to discount the importance of regulation and oversight; overlooked conflicts of interest; and shortchanged discussion of the social and moral implications of science policy. Surely this is the wrong approach to a progressive politics of science.
Obama overturns Bush policy on stem cellsby Philip ElliottAssociated PressMarch 9th, 2009President Barack Obama cleared the way for a significant increase in federal dollars for embryonic stem cell research.
Beyond stem cells: Public interest group urges strong regulation and oversight of reproductive and genetic biotechnologiesCenter for Genetics and Society welcomes stem cell policy shiftMarch 9th, 2009CGS welcomed the new federal funding policy for stem cell research announced by President Barack Obama, and called for Congress and the NIH to heed his directive for "strict guidelines" that they "rigorously enforce."
Obama Is Leaving Some Stem Cell Issues to Congress by Sheryl Gay StolbergNew York TimesMarch 8th, 2009President Obama intends to avoid the thorniest question in the stem cell debate.
Playing the Gene Card? A Report on Race and Human Biotechnologyby Osagie ObasogieAn ever-increasing number of DNA-based products are being promoted and sold. While many have important benefits, "Playing the Gene Card?" focuses on three that pose particular risks for African American and other minority communities.
Presidential Genes?by Pete ShanksBiopolitical TimesJanuary 20th, 2009Should we be looking at future candidates' genomes to discover if they have the qualities we need in a president?
A new tune for CAMR? Hopefully so.by Jesse ReynoldsBiopolitical TimesJanuary 16th, 2009The Coalition for the Advancement of Medical Research (CAMR) seems to be trying to both cool the stem cell wars and to keep them alive
Racism and Genomesby Pete ShanksBiopolitical TimesJanuary 9th, 2009A Turkish politician has called for the Turkish President's genome to be analyzed to disprove his ethnic purity.
A Call for a New Federal Embryonic Stem Cell Research Agendaby Rick WeissCenter for American ProgressDecember 4th, 2008The incoming Obama administration will soon have the opportunity to reassert U.S. scientific leadership in two of the most exciting and promising fields of biomedical research - embryonic stem cell science and regenerative medicine.
Obama and the future of stem cell politicsby Marcy DarnovskyBiopolitical TimesNovember 26th, 2008Remember stem cell politics during the 2004 presidential campaign? What a difference four years make.
Moreno to lead bioethics during presidential transitionby Jesse ReynoldsBiopolitical TimesNovember 18th, 2008Jonathan Moreno has been appointed to the transition team of US President-elect Obama.
Obama and the New Biopolitical ChallengeNovember 12th, 2008President-elect Obama's broadly expressed values and beliefs augur well for efforts to ensure responsible oversight of the new human biotechnologies. But challenges remain.
Green's surprising turn on stem cellsby Jesse ReynoldsBiopolitical TimesNovember 12th, 2008Does Ronald Green's new found moderation on stem cells represent a change in his perspective, or a shift to accommodate the changed political landscape, or something else?
RIP: Stem Cells in Politics (2002-2008)by Jesse ReynoldsBiopolitical TimesNovember 5th, 2008Michigan may have passed its stem cell research initiative, but the real message from this election cycle is the end of embryonic stem cell research as a relevant political issue.
All the President’s Genes?by Pete ShanksBiopolitical TimesNovember 5th, 2008Some are proposing that we begin to judge candidates by genotype instead of superficial aspects of phenotype
The Race Card in Michiganby Osagie ObasogieBiopolitical TimesNovember 3rd, 2008Opponents of Proposal 2 tend to view embryos as an early form of human life and therefore see embryonic stem cell research as unethical human experimentation. To bolster their moral claim regarding the use of vulnerable subjects in scientific research, they are now comparing embryonic stem cell research to the Tuskegee experiment.
Another November, Another Stem Cell Ballot Measureby Jesse ReynoldsBiopolitical TimesOctober 28th, 2008For the fourth time in five years, there's an embryonic stem cell research (ESCR) initiative on a state ballot.
Mich. Ad Likens Stem-Cell Work to Tuskegee Studyby David EggertAssociated PressOctober 23rd, 2008A television ad created by opponents of a ballot measure that would allow embryonic stem-cell research in Michigan likens such work to the infamous Tuskegee syphilis study.
Science Goes Under the Political Microscopeby Alan BoyleMSNBCOctober 20th, 2008Look close to see how campaigns differ on stem cells, climate and more
McCain Equates Embryos and Fetuses in Stem Cell Statement[Quotes CGS's Jesse Reynolds]by Brandon KeimWiredOctober 19th, 2008John McCain's recent statement on embryonic stem cell research was ambiguous in some ways, but clearly misleading in another: He equated human embryos with fetuses, and used language implying that farming fetuses for their tissues is a realistic possibility.
Third Time a Charm for Stem Cell Bill? Probably Notby Jesse ReynoldsBiopolitical TimesOctober 4th, 2008A bill to overturn restrictions on the federal funding of human embryonic stem cell research has been introduced. Why introduce a bill that has no real chance of becoming law?
A Better Road for Obama on Stem Cells by Jesse ReynoldsBiopolitical TimesSeptember 25th, 2008Obama needs to put his opponent on the spot for his recent wavering on whether he would, if elected, actually lift the restrictions on the federal funding of embryonic stem cell research.
Cures, jobs, ethics on the line in vote on stem cell researchOpposing sides dig in as vote nears on Proposal 2by Megha SatyanarayanaDetroit Free PressSeptember 24th, 2008Michigan voters will decide the emotionally charged issue of embryonic stem cell research on the basis of a 100-word ballot initiative.
Stem cell backers question where McCain standsby Ryan J. FoleyAssociated PressSeptember 22nd, 2008Some of the nation's top embryonic stem cell research advocates say they are growing concerned that Sen. John McCain will backtrack on his previous support for the work if elected president.
McCain Equates Embryos and Fetuses in Stem Cell Statement[quotes Jesse Reynolds]by Brandon KeimWiredSeptember 19th, 2008John McCain's recent statement on embryonic stem cell research was ambiguous in some ways, but clearly misleading in another: He equated human embryos with fetuses, and used language implying that farming fetuses for their tissues is a realistic possibility.
The spitterati and trickle-down genomicsby Marcy DarnovskyBiopolitical TimesSeptember 17th, 200823andMe's use of celebrities and glitzy parties to promote its direct-to-consumer DNA tests has deflected attention from the concerns and criticisms of physicians, bioethicists, and regulators.
Inequality and Human Genetics[Letter to the editor]by Richard HayesThe New York TimesSeptember 16th, 2008The genetic modification of our children is a practice that conservatives and liberals alike should be able to agree poses far more risks than benefits, and should be taken off the table as an option.
Stem Cells Enter the Presidential Election; Doublespeak Followsby Jesse ReynoldsBiopolitical TimesSeptember 16th, 2008We continue to hope that stem cell research won't be used as a political football during this American election season. But in the last week, we've seen some discouraging signs.
Neo-con logic: Designer babies for all by Marcy DarnovskyBiopolitical TimesSeptember 10th, 2008A neo-conservative pundit endorses inheritable genetic enhancement.
The Gene Poll[Quotes CGS's Marcy Darnovsky]by Eric WahlgrenThe Journal of Life SciencesSeptember 2nd, 2008Researchers say heritability plays a role in voter turnout.
Republicans Toughen on Embryonic Research. Will McCain Follow?by Jesse ReynoldsBiopolitical TimesAugust 28th, 2008The Republican party platform, to be unveiled next week, will take a much harder line than before against research that uses embryos. And John McCain has left himself enough wiggle room to move to the right.
Stem Cell Research and the Presidential Candidatesby Jesse ReynoldsBiopolitical TimesAugust 19th, 2008Over the weekend, the presumptive presidential candidates of the major American political parties each described their positions on embryonic stem research, although the issue is unlikely to feature during the campaign.
Partisan fratricide over stem cells in Missouri?by Jesse ReynoldsBiopolitical TimesJune 6th, 2008Just when you thought that the strange saga of stem cell research policy in Missouri was over, think again.
Dutch Cabinet Crisis Averted... For NowJust a storm in a test tube?by RNW's Dutch serviceRadio Netherlands WorldwideMay 31st, 2008Dutch Prime Minister Jan Peter Balkenende's fourth cabinet has narrowly avoided its first internal crisis caused by the domestic practice of carrying out tests for certain genetic defects on embryos during IVF treatment.
UK's Prime Minister Brown vs. scientistsby Jesse ReynoldsBiopolitical TimesMay 22nd, 2008Like so many writings advocating cloning-based stem cell research, UK Prime Minister Gordon Brown's recent op ed drifts to distortion and hyperbole.
Leading Scientists Tell Politicians to Stop Interfering Over Ethics of Embryo Researchby Steve ConnorThe IndependentApril 15th, 2008Politicians have been warned not to block scientific inquiry into subjects such as stem cells and embryo research just because there is a difference of opinion on the ethics or morality of the work.
How to Break the Stem Cell Logjamby Jesse ReynoldsBioethics ForumApril 4th, 2008The stem cell wars may be cooling. But both sides need to take this opportunity seriously.
One gene, two genes; Red genes, blue genesby Jesse ReynoldsBiopolitical TimesFebruary 14th, 2008The cover of a recent issue of New Scientist conveniently captures almost all that is wrong with media coverage of genetic discoveries.
Doubts on ScienceDebate2008 from Natureby Jesse ReynoldsBiopolitical TimesFebruary 8th, 2008The journal Nature has raised serious apprehension about the proposal for a presidential candidates' debate on science.
Are political leanings all in the genes?by Jim GilesNew ScientistFebruary 2nd, 2008According to an emerging idea, political positions are substantially determined by biology and can be stubbornly resistant to reason.
Cloning Critics Split [PDF][Quotes CGS's Richard Hayes]by Neil MunroNational JournalFebruary 2nd, 2008Concern about cloning animals doesn't overlap with stances on human cloning.
Update: Mooney on the Office of Technology Assessmentby Jesse ReynoldsBiopolitical TimesJanuary 14th, 2008A couple months ago, I wrote about presidential candidate Senator Hillary Clinton and her reference to reviving the Office of Technology Assessment. Chris Mooney provides an update for the Center for American Progress, and his outlook is not optimistic.
The More Things Change...by Jesse ReynoldsBiopolitical TimesJanuary 10th, 2008The leading annual public opinion survey concerning biotechnology was recently released. But the deeper I dug into the data, the less relevance I found.
A Science Debate?by Jesse ReynoldsBiopolitical TimesDecember 24th, 2007A group of science advocates are circulating a public statement calling for a presidential candidate debate on science and technology. But the framing of the issue thus far does not make me optimistic that the right questions would be asked.
Stem cell cheerleading and hand-wringing at The New York Timesby Marcy DarnovskyBiopolitical TimesDecember 4th, 2007The Times has a biotech hype problem on its editorial page, where over-the-top stem cell fervor long ago left thoughtful assessment behind.
Stem Cell Breakthrough Could Stifle Researchby Christopher WanjekLiveScienceNovember 27th, 2007Never has such a breakthrough been so worrisome to scientists.
Human Skin Cells Altered to Be PluripotentEffect on Debate Unclear [Quotes CGS's Jesse Reynolds]by Jeannie Baumann and Joyce CutlerBureau of National AffairsNovember 24th, 2007As debate continues over whether and how to fund embryonic stem cell research, two groups of scientists report on a method of generating pluripotent stem cells from adult human skin cells, possibly offering a way to exploit this promising field of research without raising some of the ethical questions.
Stem-Cell Science Outruns Political Debateby Marcy DarnovskySan Jose Mercury NewsNovember 23rd, 2007There's a right way and a wrong way to join politics and science; the stem-cell debate offers a prime example of how not to do it.
NEWS ANALYSIS: Advance on Stem Cells Equalizes Debateby Sheryl Gay StolbergNew York TimesNovember 21st, 2007Now that scientists in Japan and Wisconsin have apparently achieved what Mr. Bush envisioned, the White House is saying, "I told you so."
Hillary Clinton and the Office of Technology Assessmentby Jesse ReynoldsBiopolitical TimesOctober 19th, 2007Presidential candidate Sen. Hillary Clinton used the fiftieth anniversary of the Soviet Sputnik launch to unveil her science platform. What about her plan to revive Congress's long-defunct Office of Technology Assessment?
Reflections on Repro-GeneticsLiberals and Progressives Weigh InGenetic CrossroadsJuly 26th, 2007Several liberal and progressive commentators have weighed in recently on emerging reproductive and genetic technologies.
Thoughts on Biotech and Choiceby Marcy DarnovskyBiopolitical TimesJuly 19th, 2007Sam Berger, soon-to-be-former research assistant with the Progressive Bioethics Initiative at the Center for American Progress, has written a thoughtful piece on the "novel challenge" for pro-choice progressives presented by human biotechnologies.
Rights and Wrongs: Liberals, progressives, and biotechnologyby Will SaletanSlateJuly 13th, 2007"Bioethics has become politics by another name. Why are liberals playing this game? Because conservatives beat them to it.
Bigger than Dolly?by Jesse ReynoldsGenetic CrossroadsJune 29th, 2007Here in the United States, political maneuverings around embryonic stem cell research made headlines throughout June. But this was little more than rehearsed political theatre, reenacting a well-known script.
[Opinion] Red science vs. blue scienceby Ellen GoodmanSeattle TimesJune 16th, 2007The research raised the possibility that we might eventually be able to make stem cells without destroying human embryos.
Scientists Use Skin To Create Stem Cellsby Rick WeissWashington PostJune 7th, 2007Three teams of scientists said yesterday they had coaxed ordinary mouse skin cells to become what are effectively embryonic stem cells without creating or destroying embryos in the process
Of Stem Cells and Heartstringsby Dana MilbankWashington PostApril 13th, 2007For those who have always thought politicians are a sick bunch, this week's Senate debate on stem cell research provided ample confirmation. With yesterday's debate on the Senate floor, the Oprahfication of American politics is nearly complete.
Our Biopolitical Future: Four Scenarios [PDF]World WatchFebruary 28th, 2007CGS Executive Director Richard Hayes's essay is the cover story of the March/April issue of World Watch magazine. The four scenarios, which cover the years between 2007 and 2021, are Libertarian Transhumanism Triumphs, One Family, One Future, A Techno-Eugenic Arms Race, and For the Common Good.
File Under: Hypeby Jesse ReynoldsBiopolitical TimesJanuary 24th, 2007US Senator Arlen Spector, a Republican from Pennsylvania: "It is scandalous that eight years have passed since we have known about stem cell research and the potential to conquer all known maladies, and federal funds have not been available for the research."
Vote on Stem Cell Research Spotlights Need for Federal OversightJanuary 10th, 2007The stem cell research bill that is expected to pass the House of Representatives tomorrow is a welcome sign of significant bipartisan support on an issue that until now has been divisive. However, bipartisan support poses challenges for research advocates.
A Majoritarian Proposal for Governing Human Biotechnologyby Richard HayesBioethics ForumJanuary 3rd, 2007CGS's Executive Director reviews a proposal for comprehensive oversight of human biotechnologies, recently issued by Francis Fukuyama and Franco Furger.
A rational discussion of stem cell researchby Jesse ReynoldsBiopolitical TimesDecember 6th, 2006Check out the recent op ed in the San Jose Mercury News by my colleague and co-blogger Parita Shah, "With election over, we can discuss stem-cell research logically."
With Election Over, We Can Discuss Stem-Cell Research Logicallyby Parita ShahSan Jose Mercury NewsDecember 1st, 2006Did all of the media attention, the political mudslinging and the hundreds of millions of dollars spent on advertisements play a role in the Democrats' wins?
Opinion: A truce in the stem cell wars?by Richard HayesSan Francisco ExaminerNovember 24th, 2006"The contentious midterm elections clearly left a mark on the politics of stem cell research, but it’s not clear what the mark signifies."
New Directions for Stem Cell Politics?Genetic CrossroadsNovember 15th, 2006As the magnitude of the Democratic win in the midterm elections becomes clear, observers are pondering the new prospects for stem cell research. The election results don't support the "overwhelming mandate" or "successful wedge" interpretation of some pundits. But the political winds have clearly shifted.
'Mortal Combat' and Biotechnologyby Parita ShahBiopolitical TimesNovember 14th, 2006Check out Will Saletan's latest article in Slate, Mortal Combat: The Exploding Politics of Biotechnology.
Mortal CombatThe Exploding Politics of Biotechnologyby William SaletanSlateNovember 11th, 2006"We're so not ready for this. But we can't stop ourselves. So we try to simplify the oncoming technologies, treating them like issues we already know."
Climate change for stem cell work: Democrats may be able to override Bush's funding limits[Quotes CGS's Marcy Darnovsky]by Bernadette TanseySan Francisco ChronicleNovember 10th, 2006"Politics has long reined in stem cell research, but Tuesday's election may have put the spurs to it, industry insiders say."
Missouri's Amendment 2 both passes and failsby Jesse ReynoldsBiopolitical TimesNovember 8th, 2006The election results are in, and although Missouri's stem cell initiative passed, it did not truly succeed. A few weeks ago, I proposed three reasons why so much effort (i.e. $30 million) was behind Amendment 2. So, how did its supporters do in these regards?
Stem Cell Research in the Midterm ElectionsNovember 8th, 2006Stem cell research was again a contentious and high-profile topic in this year’s elections, but in most races its effectiveness – as a wedge issue for Democrats or a get-out-the-base issue for Republicans – remains unclear.
"Stem cell czar" at it againby Jesse ReynoldsBiopolitical TimesNovember 3rd, 2006Robert Klein, California's "stem cell czar," is inappropriately politicking again. This time, he's endorsed Democrat John Garamendi for Lt. Governor. It's my understanding that as an appointed state official, he is prohibited from endorsing candidates for office. The way he introduces his endorsement suggests he knows this.
Do stem cells work as a wedge?by Jesse ReynoldsBiopolitical TimesOctober 27th, 2006Leading into the midterm elections, many saw support for stem cell research as a way for Democrats to peel off moderate Republicans and independents. The jury's still out, but some polls suggest this assumption is off base.
How low can stem cell ads go?by Marcy DarnovskyBiopolitical TimesOctober 26th, 2006This week’s stem cell ads reach new lows of emotional manipulation in an already degraded debate. And with the help of YouTube, they’re reaching stratospheric new heights in political influence.
Stem Cell Issue Roils Missouri Raceby David LiebAssociated PressOctober 26th, 2006"The battle over stem cell research in Missouri doesn't lack for star power. Ailing actor Michael J. Fox, rock star cancer-survivor Sheryl Crow, Super Bowl hero Kurt Warner, World Series pitcher Jeff Suppan and celebrities galore have all given voters their two cents"
The Stem Cell Debate Gets Filthyby Parita ShahBiopolitical TimesOctober 25th, 2006
Stem Cells in Election Season: Surprisingly Low ProfileGenetic CrossroadsOctober 20th, 2006
Hope, unfulfilled promises on stem cell workby Sally LehrmanBoston GlobeOctober 1st, 2006"Scientists in many fields have sometimes exaggerated the importance of their work. But stem cell researchers seem uniquely inclined toward dramatic claims."
After the vote and the veto: Making sense of stem cell politicsGenetic CrossroadsAugust 4th, 2006
Beliefsby PETER STEINFELSNew York TimesJuly 22nd, 2006"At play in the case of embryonic stem cell research is the bedrock American belief in the power of science and the promise of medical cures."
Senate to Consider Stem Cell Proposalsby Rick WeissWashington PostJune 30th, 2006"Senate leaders from both parties agreed yesterday to schedule a vote on a package of bills that would loosen President Bush's five-year-old restrictions on human embryonic stem cell research."
Progressive Values and Stem Cell Research at Take Back AmericaGenetic CrossroadsJune 29th, 2006
Reframing the Politics of Stem Cell Research [PDF]June 20th, 2006A one-page overview of the politics of stem cell research.
Stem Cell Politics and Progressive Valuesby Marcy DarnovskyJune 15th, 2006Presentation at "Take Back America conference," Washington, DC
Prospects murky for US stem cell fundingby Ted AgresThe ScientistJune 8th, 2006"Leading U.S. senators are hoping to remove political roadblocks and pass legislation allowing the National Institutes of Health (NIH) and other agencies to make Federal research funds available for newly derived human embryonic stem cells (hESC). "
Institute's chairman raps senator for billby Terri SomersSan Diego Union-TribuneJune 8th, 2006"One day before voters went to the polls, the chairman of the state stem cell institute sent a scathing letter to patient advocates around California alleging that secretary of state candidate Sen. Deborah Ortiz was on an _anti-research crusade._ "
Stem Cell Cautionby Richard HayesTom PaineMay 24th, 2006"I'm worried because in their over-the-top enthusiasm for stem cell and cloning research, Democrats are ignoring the many ways in which it could, if irresponsibly promoted and inadequately regulated, have consequences at odds with core Democratic values."
Liberals and Their Ill-Liberal Policiesby Daniel CallahanBioethics ForumMay 11th, 2006"Why, for instance, does stem cell research receive such political support, and money, while many more pressing needs exist in this country?"
Democrats push for stem cell vote in US SenateReutersMay 4th, 2006"Senate Democrats sought on Thursday to jump-start a long-awaited debate on legislation to allow federal funding of embryonic stem cell research by considering it while it debates other health measures this month."
Letter to the Editor: Stem Cell Politicsby Richard HayesNew York TimesMay 1st, 2006"But over-the-top promotion of this research is a mistake that could come back to bite us, and its use as a wedge issue is ill advised. "
Democrats Hope to Divide G.O.P. Over Stem Cellsby SHERYL GAY STOLBERGNew York TimesApril 24th, 2006"Democrats are pressing their support for embryonic stem cell research in Congressional races around the country, seeking to move back to center stage an issue they believe resonates with voters and to exploit a division between conservatives..."
Federal funding for embryonic stem cell studies gets a boostby Joel B. FinkelsteinAmerican Medical NewsAugust 22nd, 2005While the fate of federal legislation to expand funding of embryonic stem cell research is unclear, states are moving ahead with their own programs.
Senator Frist's stem cell shiftGenetic CrossroadsAugust 4th, 2005
New Cloning Study and Federal Stem Cell Bill Highlight Need for Strong Biotechnology OversightProgressive public interest group calls Castle-DeGette bill "a step in the right direction, but tougher oversight is still needed."May 20th, 2005
Conservatives Draft a 'Bioethics Agenda' for Presidentby Rick WeissWashington PostMarch 8th, 2005In a split with those to their right, a group of conservative bioethicists is working on a new bioethics agenda, including de-linking legislation regarding reproductive cloning from that concerning research cloning and stem cell research.
Opinion: Rich Guys With Causes Lack Accountabilityby David WesselWall Street JournalJanuary 20th, 2005Columnist David Wessel: "Mr. Klein is walking a fine line between promoting scientific research free of political constraints and using his mastery of the initiative process to create a taxpayer-funded institute that he essentially controls."
Second-guessing Prop. 71by Tali Woodward and Laura M. AllenSan Francisco Bay GuardianDecember 22nd, 2004The weekly Bay Guardian takes on Sen. Ortiz, the San Francisco Chronicle, and the Los Angeles Times for not voicing their concerns over California's Proposition 71 before the election.
'Altered Nuclear Transfer-ANT' Crosses Ethical Boundaries [PDF]by International Center for Technology AssessmentDecember 3rd, 2004
Clone Ban Unlikely to Pass Senateby Kristen PhilipkoskiWired NewsNovember 8th, 2004After the 2004 elections, the prospect of a bill prohibiting both reproductive and research cloning passing the Senate remain unlikely.
State health props may set national trendby Rebecca VeselySan Mateo Country TimesOctober 31st, 2004California voters could sway national policies when they vote on Proposition 71, the California Stem Cell Research Initiative
The End Runby William Dean HintonSilicon Valley/Santa Cruz MetroOctober 27th, 2004A coalition of South Bay activists stands poised to topple President Bush's go-slow stem cell policy
Foes closing the gap in stem-cell measureby Carl T. HallSan Francisco ChronicleOctober 15th, 2004"Some cracks are forming in what had appeared to be a solid base of support among progressives and the medical establishment for Prop. 71."
Stem cell bond issue has narrow lead in pollAssociated PressOctober 11th, 2004In a recent poll of voters' positions on California's Proposition 71, 46 percent of likely voters support the idea with 39 percent opposed and 15 percent undecided.
Scientists split over stem cell measureby Keri BrennerMarin Independent JournalOctober 10th, 2004"[T]he debate over Prop. 71 does not break down into camps, such as the religious right versus the liberal left, or Republican versus Democrat. Some local scientists who otherwise back stem cell research say they have strong concerns about the measure."
Pro-Choice Genetics Think Tank Criticizes California Stem Cell Initiative; Is Encouraged by Kerry ProposalOctober 5th, 2004
Governor In Tight Political Spot On Stem Cell ResearchAssociated PressAugust 5th, 2004California Gov. Schwarzenegger has said he supports stem-cell technology, but he is not expected to take a position on Proposition 71.
Missed Message: Deeper Analysis of the President’s Council on Bioethics ReportGenetic CrossroadsJuly 11th, 2002
Congress Debates Cloning's Two Branchesby Tom Abate San Francisco ChronicleJune 17th, 2002
End Game in the Senate Cloning DebateGenetic CrossroadsJune 12th, 2002
Break the Cloning Deadlockby Richard HayesChristian Science MonitorJune 10th, 2002After a year of intense debate, the US Senate is set to vote on human cloning. Is there a way to break this deadlock? Yes, but it will require of both sides a realization of what is at stake and a willingness to compromise.
It's worth copying Canada's model for cloning legislationby Richard HayesSeattle TimesJune 3rd, 2002The United States should take the Canadian experience to heart. A broad and informed debate is essential if we are to realize the best and avoid the worst that the new genetic technologies have to offer. We cannot afford to do less on a matter of such consequence.
INCREASINGLY DANGEROUS POLARIZATION ON HUMAN CLONINGGenetic CrossroadsApril 30th, 2002
A Timeout on Cloning Embryosby Richard HayesBaltimore SunApril 23rd, 2002The U.S. Senate is set to vote on human cloning within the next few weeks. Unfortunately, a polarized political climate and lack of political leadership could block urgently needed legislation.
Cloning: Now You See You, Now You See Two? The Dallas Morning NewsApril 22nd, 2002
Nucleus of the debateCall a timeout on cloning embryos for researchby Richard HayesSan Francisco ChronicleApril 17th, 2002Human Cloning will soon be voted on by the U.S. Senate. Unfortunately, a polarized political climate and lack of political leadership could block urgently needed legislation.
Coalition Urges a Ban on All Human Cloningby Mary LeonardThe Boston GlobeMarch 22nd, 2002
Liberal Anti-Cloners Up to Batby Kristen PhilipkoskiWiredMarch 19th, 2002A group of self-proclaimed liberal, pro-choice leaders held a press conference Tuesday to influence the Senate's votes on an anti-cloning bill.
Cloning Creates Odd Bedfellowsby Rick WeissThe Washington PostFebruary 10th, 2002
Women's Health and Reproductive Rights Leaders Call for Cloning BanGenetic CrossroadsAugust 18th, 2001
Odd-Couple Pairing in US Cloning Debate: Abortion-Rights Activists Join GOP Conservatives by Tom AbateSan Francisco Chronicle August 9th, 2001
Cloning and the Debate on Abortionby Nigel Cameron and Lori AndrewsChicago TribuneAugust 8th, 2001
It's a Bird. . . It's a Plane. . . It's Supercloneby Katha Pollitt The Nation August 6th, 2001
What Cloning Has Wroughtby Gia Fenoglio National Journal MagazineAugust 4th, 2001
Unlikely Allies on Cloningby E. J. Dionne Jr.The Washington PostAugust 3rd, 2001
Ban Human Cloning Right Nowby Judy Norsigian and Stuart NewmanBoston GlobeAugust 3rd, 2001
Odd Mix of Activists Stands Together against CloningCoalition Supports Bill That Could Mean Fines, Prison Time for Scientists Involved in Practiceby Richard WillingUSA TodayJuly 16th, 2001
TWO BILLS: A REAL CLONING BAN AND A BAN THAT ISN'T ONEGenetic CrossroadsJune 21st, 2001
HUMAN CLONING UPDATEGenetic CrossroadsMay 16th, 2001
US CONGRESS TO CONSIDER BAN ON HUMAN CLONINGGenetic CrossroadsMarch 31st, 2001
UPCOMING EVENTSGenetic CrossroadsJanuary 7th, 2001
The Case Against Designer BabiesThe Politics of Genetic Enhancementby Marcy DarnovskyRedesigning Life? The Worldwide Challenge to Genetic Engineering, edited by Brian Tokar, New York: Zed Books, 2001November 30th, 2000
SuperhumansLike it or not, in a few short years we'll have the power to control our own evolutionby Robert Taylor New ScientistOctober 1st, 1998

ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760